CHEK2 and cancer: Interestingly, CHEK2 GPV identified in 6/123 (4.9%) early-onset OC patients were significantly associated with earlier age at diagnosis compared to previously analyzed OC patients negative for GPV in HBOP cancer predisposition genes6.